B Phillips, K Nylander, J Harnaha, J Machen, R … - Diabetes, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Microspheres carrying antisense oligonucleotides to
CD40, CD80, and CD86 were delivered into NOD mice. Glycemia was monitored to determine
disease prevention and reversal. In recipients that remained and/or became diabetes ... Cited by 9 - Related articles - All 11 versions
D Elias, A Avron, M Tamir, I Raz - ANNALS-NEW YORK …, 2006 - interscience.wiley.com Abstract: DiaPep277 is an immunomodulatory peptide that arrests β cell destruction in mouse
models of type 1 diabetes mellitus (T1DM). This article extends an original pilot observation to
two studies of 61 patients (age > 16 years), diagnosed with T1DM within 6 months, and ... Cited by 4 - Related articles - BL Direct - All 4 versions
M Yoshida, JE Babensee - Journal of Biomaterials Science, …, 2006 - ingentaconnect.com Abstract—The ability of immature dendritic cells (iDCs) derived from human peripheral blood
mononuclear cells to phagocytose poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) as
compared to polystyrene MPs and the molecular aspects of this phagocytosis were ... Cited by 12 - Related articles - BL Direct - All 5 versions
AH Enk - Ernst Schering Research Foundation workshop, 2006 - ncbi.nlm.nih.gov Regulatory T cells (Treg) in broader terms consist of different subsets of T cells that are characterized
by their ability to suppress proliferation of conventional effector T cells by various means. To
date, three main groups of Treg can de distinguished, mainly by their functional properties ... Cited by 8 - Related articles
M Nouri-Shirazi, AW Thomson - Expert Opin. Biol. Ther., 2006 - informahealthcare.com Dendritic cells (DCs) play a crucial role during the initiation of immune responses against
non-self antigens. Following organ transplantation, activated donor- and recipient-derived DCs
participate actively in graft rejection by sensitising recipient T cells via the direct or indirect ... Cited by 17 - Related articles - BL Direct - All 5 versions
C Ionescu-Tîrgoviºte - Acta Endocrinologica (Buc), 2009 - 82.76.72.38 Abstract Based on epidemiological, clinic, biochemical and hormonal data (both personal and
international), our personal view is that natural history of autoimmune type 1 diabetes could include
the following stages: 1) The presence of a complex genetic predisposition towards β cell ... Related articles - View as HTML - All 2 versions
AP Acharya, MJ Clare-Salzler, BG Keselowsky - Biomaterials, 2009 - Elsevier Immunogenomic a combined with advances in adjuvant immunology are guiding progress toward
rational design of vaccines. Furthermore, drug delivery platforms (eg, synthetic particles) are
demonstrating promise for increasing vaccine efficacy. Currently there are scores of ... Related articles - All 2 versions
B Phillips, N Giannoukakis, M Trucco - Expert Review of Clinical …, 2009 - ingentaconnect.com Dendritic cell (DC) immunotherapy is a clinical reality. Despite two decades of considerable data
demonstrating the feasibility of using DCs to prolong transplant allograft survival and to prevent
autoimmunity, only now are these cells entering clinical trials in humans. Type 1 diabetes ... Related articles - All 3 versions
